Dynamic Contrast-Enhanced MRI Kinetics of Invasive Breast Cancer: A Potential Prognostic Marker for Radiation Therapy

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 5, 2010, Pages 1314-1319

  Loiselle, Christopher R ^a   Eby, Peter R ^a,b   DeMartini, Wendy B ^a,b   Peacock, Sue ^a,b   Bittner, Nathan ^a   Lehman, Constance D ^a,b   Kim, Janice N ^a,b  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b SEATTLE CANCER CARE ALLIANCE   (United States)

Author keywords

Axillary nodes; Breast cancer; MRI; Patient selection; Radiation therapy

Indexed keywords

AXILLARY NODES; BREAST CANCER; DCE-MRI; DYNAMIC CONTRAST ENHANCED MRI; EVALUATION PROGRAM; EXTERNAL BEAM RADIOTHERAPY; KINETIC DATA; KINETIC VALUES; LESION SIZE; MULTI VARIATE ANALYSIS; NODAL STATUS; NODE-NEGATIVE; NODE-POSITIVE; RADIATION THERAPY; RECEIVER OPERATING CHARACTERISTIC CURVE ANALYSIS; SURGICAL STAGING; UNIVARIATE;

CHEMOTHERAPY; DECISION MAKING; MULTIVARIANT ANALYSIS; PATIENT MONITORING; TUMORS;

RADIOTHERAPY;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; COMPUTER AIDED DESIGN; CONTRAST ENHANCEMENT; EXTERNAL BEAM RADIOTHERAPY; HUMAN; KINETICS; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TUMOR VOLUME;

ANALYSIS OF VARIANCE; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CONTRAST MEDIA; FEMALE; HUMANS; LYMPH NODES; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 77949556765     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.03.053     Document Type: Article

References (34)

1. Kuhl C. The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology 244 (2007) 356-378
2. Kuhl C.K. Current status of breast MR imaging. Part 2. Clinical applications. Radiology 244 (2007) 672-691
3. Lehman C.D., Blume J.D., Weatherall P., et al. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 103 (2005) 1898-1905
4. Warner E., Plewes D.B., Hill K.A., et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292 (2004) 1317-1325
5. Kriege M., Brekelmans C.T., Boetes C., et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351 (2004) 427-437
6. Lehman C.D., Blume J.D., Thickman D., et al. Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) trial. J Surg Oncol 92 (2005) 9-15 discussion 15-16
7. Lehman C.D., Gatsonis C., Kuhl C.K., et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 356 (2007) 1295-1303
8. Lee S.G., Orel S.G., Woo I.J., et al. MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results. Radiology 226 (2003) 773-778
9. Szabo B.K., Aspelin P., Kristoffersen Wiberg M., et al. Invasive breast cancer: correlation of dynamic MR features with prognostic factors. Eur Radiol 13 (2003) 2425-2435
10. Tuncbilek N., Karakas H.M., and Okten O.O. Dynamic magnetic resonance imaging in determining histopathological prognostic factors of invasive breast cancers. Eur J Radiol 53 (2005) 199-205
11. Montemurro F., Martincich L., Sarotto I., et al. Relationship between DCE-MRI morphological and functional features and histopathological characteristics of breast cancer. Eur Radiol 17 (2007) 1490-1497
12. Agrawal G., Chen J.H., Baek H.M., et al. MRI features of breast cancer: a correlation study with HER-2 receptor. Ann Oncol 18 (2007) 1903-1904
13. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b trial. N Engl J Med 337 (1997) 949-955
14. Overgaard M., Jensen M.B., Overgaard J., et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353 (1999) 1641-1648
15. Ragaz J., Jackson S.M., Le N., et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337 (1997) 956-962
16. Ragaz J., Olivotto I.A., Spinelli J.J., et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 97 (2005) 116-126
17. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 (2002) 1233-1241
18. Veronesi U., Cascinelli N., Mariani L., et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347 (2002) 1227-1232
19. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet 365 (2005) 1687-1717
20. Overgaard M., Nielsen H.M., and Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol 82 (2007) 247-253
21. NCCN Breast Cancer Panel. NCCN practice guidelines in oncology (version 2). http://www.nccn.org/professionals/physician_gls/PDF/breast.pdf.
22. Yildirim E., and Berberoglu U. Can a subgroup of node-negative breast carcinoma patients with T1-2 tumor who may benefit from postmastectomy radiotherapy be identified?. Int J Radiat Oncol Biol Phys 68 (2007) 1024-1029
23. Truong P.T., Olivotto I.A., Kader H.A., et al. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 61 (2005) 1337-1347
24. Truong P.T., Woodward W.A., Thames H.D., et al. The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1-3 positive nodes: an analysis of prospective data from British Columbia and the M.D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys 68 (2007) 59-65
25. Huang E.H., Tucker S.L., Strom E.A., et al. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy. J Clin Oncol 22 (2004) 4691-4699
26. McGuire S.E., Gonzalez-Angulo A.M., Huang E.H., et al. Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys 68 (2007) 1004-1009
27. Carter C.L., Allen C., and Henson D.E. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63 (1989) 181-187
28. Mussurakis S., Buckley D.L., and Horsman A. Prediction of axillary lymph node status in invasive breast cancer with dynamic contrast-enhanced MR imaging. Radiology 203 (1997) 317-321
29. Bahri S., Chen J.H., Yu H.J., et al. Can dynamic contrast-enhanced MRI (DCE-MRI) predict tumor recurrence and lymph node status in patients with breast cancer?. Ann Oncol 19 (2008) 822-824
30. Rivers A., and Hansen N. Axillary management after sentinel lymph node biopsy in breast cancer patients. Surg Clin North Am 87 (2007) 365-377
31. Van Zee K.J., Manasseh D.M., Bevilacqua J.L., et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10 (2003) 1140-1151
32. Katz A., Smith B.L., Golshan M., et al. Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer. J Clin Oncol 26 (2008) 2093-2098
33. Jones C.M., and Athanasiou T. Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests. Ann Thorac Surg 79 (2005) 16-20
34. Jeruss J.S., Mittendorf E.A., Tucker S.L., et al. Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy. J Clin Oncol 26 (2008) 246-252